Canine Parvovirus Clinical Trial Completed
Canine Parvovirus Clinical Trial Completed
About the Research:
The clinical trial was designed on Canine Parvovirus Infections, a member of the Parvoviridae Virus family, which is a DNA virus highly resistant to disinfectants and capable of surviving outside the body for 4-6 weeks due to its molecular structure consisting solely of proteins.
Canine Parvovirus Infection, one of the most dangerous outbreaks observed in dogs, is an acute infection with high lethality for dogs during specific periods. There is no established treatment for the disease, commonly known as bloody diarrhea. In the absence of any supportive treatment, the infection has a mortality rate of 90% and above.
Study Details:
|
Pathogen:
|
Canine Parvovirus
|
|
Infection Name:
|
Canine Parvoviral Enteritis, Canine Parvoviral Myocarditis
|
|
Patients:
|
Client-owned dogs
|
|
Age Group:
|
6-60 months
|
|
Gender:
|
Male/Female
|
|
Research Center:
|
2 centers
|
|
Number of Patients:
|
20 Dogs
|
|
Groups:
|
Standard treatment and Dr Biolyse® treatment group
|
|
Design:
|
Controlled, prospective
|
Treatments Administered in the Study The patients were divided into 2 groups for the purpose of comparing values. One group was administered solely Bioelectrical Modulation with the Dr Biolyse® device, while the other group received only the standard treatment protocol.
Results
|
Progress Level:
|
100% – The study has been completed
|
|
Dr Biolyse® Treatment Efficacy Rate
|
100%
|
|
Dr Biolyse® Group Mortality Rate
|
0%
|
|
Standard Treatment Efficacy Rate
|
30%
|
|
Standard Treatment Group Mortality Rate
|
70%
|
Scope of Treatment Efficacy:
While an antiviral effect on the virus was observed, Deteriorated hematological values returned to normal, The hemorrhagic diarrhea and vomiting caused by the infection stopped completely, and the patients were discharged. No serious adverse effects were observed. The clinical trial has been completed.
This study was prospectively designed on client-owned animals and was conducted with the approval of the local animal experiments ethics committee and the permission of the Republic of Türkiye Ministry of Agriculture and Forestry, Istanbul Provincial Directorate of Agriculture and Forestry, within the framework of VICH GL9 standards and guidelines.